1h Free Analyst Time
Ajanta Pharma Ltd (AJANTPHARM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by the publisher to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.Speak directly to the analyst to clarify any post sales queries you may have.
The profile contains critical company information including:
- Business description - A detailed description of the company’s operations and business divisions.
- Corporate strategy - Analyst’s summarization of the company’s business strategy.
- SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history - Progression of key events associated with the company.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Executive biographies - A brief summary of the executives’ employment history.
- Key operational heads - A list of personnel heading key departments/functions.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights
Ajanta Pharma Ltd (Ajanta Pharma) is a specialty pharmaceutical company that focuses on the research, manufacture and commercialization of finished dosages in domestic and international markets. The company has a presence in cardiology, pain management, dermatology, and ophthalmology therapy areas. It provides generics in developed markets of USA and branded generics in emerging countries such as India, Africa, CIS, Middle East and South-East Asia. Ajanta Pharma also supplies multivitamins, eye drops, cough syrups and antibiotics to government bodies in India; and anti-malarial products to Africa and Global Fund. It operates subsidiaries in Philippines, Mauritius, Nigeria, and the US. Ajanta Pharma is headquartered in Mumbai, Maharashtra, India.Ajanta Pharma Ltd Key Recent Developments
May 29, 2023: Ajanta Pharma announces intimation of annual general meetingMay 05, 2023: Ajanta Pharma announces audited financial results for the quarter and year ended 31st March 2023
Feb 01, 2023: Ajanta Pharma Announces Unaudited Consolidated Financial Results for the quarter and nine months ended 31st December 2022
Nov 03, 2022: Ajanta Pharma Announces Financial Results for the second quarter and half year ended 30th September 2022
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Table of Contents
Section 1 - About the Company
Section 2 - Company Analysis
Section 3 - Company Financial Ratios
Section 4 - Company’s Lifesciences Financial Deals and Alliances
Section 5 - Company’s Recent Developments
Section 6 - Appendix
List of Tables
List of Figures
Samples
LOADING...
Companies Mentioned
A selection of companies mentioned in this report includes:
- Oboi Laboratories Pvt Ltd
- Kopran Ltd
- Aurobindo Pharma Ltd
- Allied Chemicals and Pharmaceuticals Pvt Ltd
- Syncom Formulations (India) Ltd
- Lyka Labs Ltd
- Biochem Pharmaceutical Industries Ltd
- Alembic Pharmaceuticals Ltd
- Profic Organic Ltd
- Cian Healthcare Ltd
- Bal Pharma Ltd